在多个模型中,高效的mRNA-LNP疫苗对抗呼吸道同胞性病毒 (RSV)
Huarong Bai1, Xueliang Yu1, Yue Gao1
1Starna Therapeutics Co., Ltd., Suzhou 215123, China.
Vaccines
|June 27, 2025
概括
一种新的呼吸道同胞性病毒 (RSV) mRNA疫苗STR-V003有效产生保护性抗体,并减少动物模型中的病毒载量. 该疫苗显示出良好的安全性,而不会导致疫苗增强的疾病.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
背景情况:
- 呼吸道同胞性病毒 (RSV) 病原体包括融合 (F) 蛋白介导病毒进入.
- F蛋白的预注射 (preF) 形式是中和抗体和疫苗开发的关键目标.
- 针对preF的抗体对于有效的RSV中和至关重要.
研究的目的:
- 设计和评估一种编码RSV preF蛋白的mRNA疫苗 (STR-V003).
- 在动物模型中评估STR-V003的免疫性,保护性有效性和安全性.
- 确定STR-V003作为RSV预防候选者的潜力.
主要方法:
- 在脂质纳米粒子 (LNP) 中封装的mRNA疫苗STR-V003的开发.
- 评估免疫性,包括中和抗体和前F特异性IgG,在小鼠和棉鼠.
- 通过测量受挑战动物的病毒载量来评估保护有效性.
- 毒理学研究,包括重复剂量和局部耐受性,在老鼠和非人类灵长类动物 (NHPs).
主要成果:
- 在小鼠和棉鼠中,STR-V003诱导了高水平的中和和前F特异性IgG抗体.
- 在接种疫苗的动物肺部和鼻腔组织中观察到RSV病毒载荷的显著减少.
- 没有发现肺病理或疫苗增强性疾病 (VED) 的显着增强.
- 毒理学研究表明,STR-V003.3的安全性概况有利.
结论:
- STR-V003显示出强大的免疫性和保护性有效性,对抗RSV的挑战.
- 开发的mRNA疫苗在临床前动物模型中表现出良好的安全性.
- STR-V003代表了有效的RSV疫苗的有希望的候选人.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


